Pharmafile Logo
Pharmafocus logo
Advanced Search
Boehringer Ingelheim

Boehringer begins late-stage hep C trial

April 27, 2011
Research and Development BI 201335, Boehringer Ingelheim, hepatitis C

Boehringer Ingelheim has begun enrolling patients in North America for a phase III trial of its chronic hepatitis C virus …

News
Bayer UK Twitter Levitra

Digital Pharma: Bayer UK’s Twitter slip-up

April 26, 2011
Medical Communications ABPI Code of Practice, Bayer, Digital Pharma blog, PMCPA, Twitter, medicial communications

There seems to be some confusion at Bayer UK over what communications can be sent over Twitter. The company is …

News

Bayer defends Yasmin against BMJ studies

April 26, 2011
Sales and Marketing Bayer, Yasmin, contraception

Bayer has rallied strongly behind its top-selling contraceptive brand Yasmin after two studies in the British Medical Journal questioned the …

News

Merck & Co kicks off expansion of Durham vaccines facility

April 26, 2011
Manufacturing and Production Merck & Co, manufacturing and production, vaccines

Merck & Co is expanding its vaccines facility in North Carolina, USA, bucking a recent trend at the manufacturer for …

News

Pharma manufacturing news in brief

April 26, 2011
Manufacturing and Production Archer Daniels Midland, Dow Chemical, IPEC Americas, Pharmatek Laboratories, Taro, Taro Pharmaceutical Industries, Teva, Teva Pharmaceutical Industries, manufacturing, manufacturing news in brief, pharma manufacturing news

Includes a formulation problem for Teva, facility updates from Taro and ADM, and a new excipient screening initiative at the …

News
Pfizer

Deaths reported in Pfizer arthritis trial

April 26, 2011
Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib

Four deaths have been reported in a late-stage study of Pfizer’s arthritis drug tofacitinib. Three of the deaths are thought …

News

Anglo-Chinese joint venture makes first API batches

April 26, 2011
Manufacturing and Production China, Hebei Aoxing Pharmaceutical, Macfarlan Smith, manufacturing and production

China’s Hebei Aoxing Pharmaceutical has passed a major milestone in its joint venture with process technology specialist Macfarlan Smith to …

News

Sten Westerberg joins BioInvent

April 26, 2011
Research and Development appointment, research and development, sales and marketing

Swedish pharma company BioInvent International has appointed Sten Westerberg to the newly-created position of vice president investor relations. Sten is …

Appointment
William Weldon

Top 5 reasons for a Class I product recall

April 21, 2011
Manufacturing and Production Johnson & Johnson, product recalls

Having to recall a pharmaceutical product because of a major quality defect or safety issue is a heart sinking moment …

Feature

Digital Pharma: Boehringer UK tweets politicians with afib message

April 21, 2011
Medical Communications Boehringer Ingelheim, Digital Pharma blog, Twitter, medical communications

Boehringer Ingelheim UK is using Twitter to reach politicians with local disease awareness messages. About a third of MPs have …

News

WPP launches UK healthcare digital division

April 21, 2011
Medical Communications Ogilvy, Ogilvy Healthworld UK, OgilvyHealthPR, WPP, medical communications, ogilvy healthworld advertising

Communications giant WPP has merged the digital activities of two media brands to launch a new entity in the UK, …

News

UCB and Amgen’s osteoporosis drug shows promise

April 21, 2011
Research and Development Amgen, UCB, osteoporosis

Amgen and UCB have announced strong results from a phase II study of their new postmenopausal osteoporosis treatment. Most existing …

News

Report sounds off-label prescribing warning

April 21, 2011
Sales and Marketing EAASM, off label

A pharma-backed group has warned that some ‘off-label’ prescribing is dangerous for patients. A report by the European Alliance for …

News

Trevor Smith to lead Takeda in Europe

April 21, 2011
Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe. Smith brings more than 30 years of pharmaceutical experience …

Appointment

Saving billions through ‘innovation’ – can the NHS pull it off?

April 21, 2011
NHS reforms

Innovation is not a concept immediately associated with the UK’s national health service, but is now being promoted by the …

Feature

Procurement pitfalls and hurdles of lab equipment for clinical trials

April 20, 2011
Research and Development clinical trials, medical equipment, mesm, procurement

 Over $78 billion is spent every year in the clinical trial market in the pursuit of bringing new drugs and …

Feature
Thought Leadership

Eisai launches cancer drug Halaven in UK

April 20, 2011
Sales and Marketing Eisai, Halaven, breast cancer

Eisai’s sea sponge derived breast cancer drug Halaven has been launched in the UK following approval from European regulators a …

News

Novavax appoints Stanley Erck chief executive

April 20, 2011
Research and Development appointment, research and development

US biopharmaceutical company Novavax has reorganised its senior management. The changes see former executive chairman Stanley Erck take on the …

Appointment

Generics push US drug growth to $307bn

April 20, 2011
IMS, IMS Health, drug spending, healthcare spending

Generics replaced branded drugs as the main growth drivers for the US pharmaceutical market in 2010. The market saw just …

News

Warner Chilcott plans to axe 500 jobs in Europe

April 20, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Warner Chilcott, pharma job cuts

Warner Chilcott is looking to cut 500 jobs from its European operations as it seeks to minimise the impact of …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026